The Food and Drug Administration is close to finishing its high-level review of a memorandum of understanding (MOU) with CBP that would allow the two agencies to share importer filing information through the International Trade Data System, said an FDA official, speaking at the National Customs Brokers and Forwarders Association of American Government Affairs Conference Sept. 23. The MOU is now with the agency's Office of the General Counsel, which is working to address some “minor issues,” said Ted Poplawski, special assistant to the director in FDA’s Division of Import Operations.
CBP issued the following releases on commercial trade and related issues:
CBP issued the following releases on commercial trade and related issues:
The Automated Commercial Environment (ACE) Cargo Release/Simplified Entry (SE) Status Notification documentation for Oct. 5 deployment was reposted online on Sept. 10 as a future ACE ABI (Automated Broker Interface) CATAIR (Customs and Trade Automated Interface Requirements) chapter (here), CBP said. CBP said the ACE Cargo Release/SE input documentation was reposted to include a correction to the Carrier Code in the SE16 record, which should be listed as 4AN to accommodate various codes. The certification environment is now available to trade members for testing.
CBP made a change to the Automated Commercial Environment (ACE) reports Sept. 7, allowing customs brokers with an ACE Secure Data Portal account to access AM-100 liquidation reports, the agency said in a CSMS message. Previously, only the importers could access the report. CBP also issued a document outlining how to use the AM-100 report (here). The agency made the reports available to importers in 2011 (see 11092912).
The posting of Importer Security Filing reports for August 2013 to the Automated Commercial Environment Portal will be delayed, CBP said. According to CBP, the reports should be posted by the week of Sept. 13.
International Trade Today is providing readers with some of the top stories for Sept. 3 - Sept. 6 in case they were missed.
CBP issued the following releases on commercial trade and related issues:
CBP’s Pharmaceutical, Health and Chemicals Center of Excellence and Expertise met with industry partners from government and private sector in August to discuss issues facing pharmaceutical, health and chemical industries such as disruptions to supply chains, CBP said. According to a news release, the CEEs “process participating importers within 10 CEE industries by account” and allow CBP to quickly adapt to industry changes. CBP said that CEE staff uses “industry knowledge to resolve holds and mitigate requests for information or CF-28s—oftentimes before the accounts know it themselves.” CEE Director Leon Hayward said these efforts reduce costs for the trade community and that the CEEs were “designed as the centerpiece of CBP’s 21st Century trade modernization efforts.” Other industry speakers called the CEEs “the nexus for engaging with the government on all questions for their imports.”
CBP issued the following releases on commercial trade and related issues: